LRPA
MDT icon

L. Roy Papp & Associates’s Medtronic MDT Stock Holding History

L. Roy Papp & Associates’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$507K Sell
6,486
-275
-4% -$22.2K 0.05% 134
2026
Q1 		$586K Buy
6,761
+27
+0.4% +$2.59K 0.07% 117
2025
Q4 		$647K Hold
6,734
– – 0.07% 116
2025
Q3 		$641K Hold
6,734
– – 0.07% 117
2025
Q2 		$587K Buy
6,734
+1,635
+32% +$139K 0.07% 122
2025
Q1 		$458K Buy
5,099
+138
+3% +$12.3K 0.06% 130
2024
Q4 		$396K Sell
4,961
-1,125
-18% -$97.4K 0.05% 137
2024
Q3 		$548K Sell
6,086
-70
-1% -$5.89K 0.07% 117
2024
Q2 		$485K Sell
6,156
-47
-0.8% -$3.85K 0.06% 123
2024
Q1 		$541K Buy
6,203
+220
+4% +$18.8K 0.06% 118
2023
Q4 		$493K Sell
5,983
-40
-0.7% -$3.05K 0.06% 118
2023
Q3 		$472K Sell
6,023
-320
-5% -$26.8K 0.06% 117
2023
Q2 		$559K Sell
6,343
-503
-7% -$43.3K 0.07% 114
2023
Q1 		$552K Sell
6,846
-1,360
-17% -$111K 0.07% 111
2022
Q4 		$638K Sell
8,206
-902
-10% -$73.1K 0.09% 109
2022
Q3 		$735K Buy
9,108
+75
+0.8% +$6.74K 0.11% 105
2022
Q2 		$811K Buy
9,033
+67
+0.7% +$6.79K 0.12% 107
2022
Q1 		$995K Buy
8,966
+495
+6% +$52.3K 0.12% 101
2021
Q4 		$876K Buy
8,471
+1,015
+14% +$118K 0.1% 104
2021
Q3 		$935K Sell
7,456
-400
-5% -$51.8K 0.12% 99
2021
Q2 		$975K Sell
7,856
-75
-0.9% -$9.42K 0.12% 98
2021
Q1 		$937K Sell
7,931
-276
-3% -$32.3K 0.13% 91
2020
Q4 		$961K Buy
8,207
+113
+1% +$12.4K 0.11% 101
2020
Q3 		$841K Buy
8,094
+235
+3% +$23.6K 0.11% 101
2020
Q2 		$721K Sell
7,859
-604
-7% -$57.9K 0.1% 106
2020
Q1 		$763K Hold
8,463
– – 0.14% 102
2019
Q4 		$960K Buy
8,463
+197
+2% +$21.6K 0.14% 95
2019
Q3 		$898K Hold
8,266
– – 0.14% 99
2019
Q2 		$805K Sell
8,266
-896
-10% -$81.8K 0.13% 104
2019
Q1 		$834K Sell
9,162
-750
-8% -$67.1K 0.15% 89
2018
Q4 		$902K Hold
9,912
– – 0.19% 86
2018
Q3 		$975K Sell
9,912
-700
-7% -$64.7K 0.17% 87
2018
Q2 		$908K Sell
10,612
-725
-6% -$60.6K 0.17% 88
2018
Q1 		$909K Sell
11,337
-426
-4% -$35.1K 0.17% 89
2017
Q4 		$950K Buy
11,763
+6,077
+107% +$487K 0.19% 88
2017
Q3 		$442K Buy
5,686
+61
+1% +$5.06K 0.1% 100
2017
Q2 		$499K Hold
5,625
– – 0.11% 107
2017
Q1 		$453K Hold
5,625
– – 0.1% 102
2016
Q4 		$401K Hold
5,625
– – 0.09% 117
2016
Q3 		$486K Sell
5,625
-350
-6% -$30.5K 0.11% 105
2016
Q2 		$518K Sell
5,975
-61
-1% -$4.93K 0.12% 108
2016
Q1 		$453K Buy
6,036
+61
+1% +$4.59K 0.11% 114
2015
Q4 		$460K Hold
5,975
– – 0.11% 104
2015
Q3 		$400K Buy
+5,975
New +$440K 0.1% 112

Other funds holding MDT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

L. Roy Papp & Associates's MDT Position: Q2 2026 in Review

L. Roy Papp & Associates reduced its Medtronic (MDT) stake by 4.1% in Q2 2026, selling an estimated $22.2K and leaving 6,486 shares worth $507K. The position accounts for 0.05% of the portfolio, ranked #134.

L. Roy Papp & Associates first reported a position in MDT in Q3 2015 and has held it in 44 quarters since. The position peaked at $995K in Q1 2022. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • L. Roy Papp & Associates held 6,486 shares of Medtronic worth $507K as of Q2 2026.
  • L. Roy Papp & Associates sold 275 Medtronic shares in Q2 2026, an estimated $22.2K.
  • Medtronic made up 0.05% of L. Roy Papp & Associates's portfolio in Q2 2026, its #134 holding.
  • L. Roy Papp & Associates first reported a position in Medtronic in Q3 2015 and has held it in 44 quarters since.
  • L. Roy Papp & Associates's Medtronic position peaked at $995K in Q1 2022.
  • 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on L. Roy Papp & Associates's 13F filing for Q2 2026, filed 23 Jul 2026.